R&D Take the hybrid road to bring clinical trials to patients As the landscape of clinical trials evolves, decentralised clinical trials (DCTs) have emerged to put patients at the centre of the research process.
Views & Analysis How AI-powered adaptive design helped Eisai launch Leqembi At DPHARM 2023 in Boston, Eisai insiders described the Bayesian design of Leqembi's phase 2 trial.
Events Partner Content 10th annual Adaptive Designs in Clinical Trials Adaptive Designs in Clinical Trials 2018
News Padcev/Keytruda scores again in early bladder cancer Pfizer and Astellas now have two studies supporting the use of Padcev with MSD's Keytruda as perioperative therapy for muscle-invasive bladder cancer.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.